Related Experiment Videos

3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation

Y Shirayama1, K Hashimoto, M Iyo

  • 1Division of Cortical Function Disorders, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Kodaira, Japan. yukihiko.shirayama@yale.edu

Insights

3,4-methylenedioxymethamphetamine (MDMA) significantly increases egr-1 mRNA in specific rat brain regions. This induction is mediated by N-methyl-D-aspartate receptors, dopamine D(1) receptors, and serotonin transporters, but not 5-HT(2A) receptors.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • The immediate-early gene egr-1 (also known as Zif268) is rapidly induced by various stimuli in the brain.
  • 3,4-methylenedioxymethamphetamine (MDMA) is a psychoactive drug with known effects on neurotransmitter systems.
  • Understanding the molecular mechanisms underlying MDMA's effects is crucial for neuroscience research.

Purpose of the Study:

  • To investigate the expression pattern of egr-1 mRNA and Egr-1 protein in rat brain regions after MDMA administration.
  • To determine the roles of N-methyl-D-aspartate (NMDA) receptors, dopamine D(1) receptors, 5-hydroxytryptamine (5-HT) transporters, and 5-HT(2A) receptors in mediating MDMA-induced egr-1 mRNA expression.

Main Methods:

  • In situ hybridization and immunohistochemical techniques were used to analyze egr-1 mRNA and Egr-1 protein expression.
  • Rats were administered MDMA (10 mg/kg) and various receptor antagonists or inhibitors prior to tissue analysis.
  • Specific brain regions examined included the prefrontal cortex, striatum, hippocampus (dentate gyrus and CA1), and occipital cortex.

Main Results:

  • MDMA administration significantly induced egr-1 mRNA in the prefrontal cortex, striatum, and hippocampal dentate gyrus.
  • No significant changes in egr-1 mRNA levels were observed in the CA1 region of the hippocampus or the occipital cortex.
  • Pretreatment with NMDA receptor antagonist ((+)-MK801), dopamine D(1) receptor antagonist (SCH 23390), or 5-HT transporter inhibitor (paroxetine) blocked MDMA-induced egr-1 mRNA expression.
  • 5-HT(2A) receptor antagonist (SR46349B) did not block the induction.
  • MDMA did not alter the high basal levels of Egr-1 protein immunoreactivity.

Conclusions:

  • MDMA alters egr-1 mRNA expression in specific rat brain regions.
  • The induction of egr-1 mRNA by MDMA in the prefrontal cortex, striatum, and hippocampal dentate gyrus is mediated by NMDA receptors, dopamine D(1) receptors, and 5-HT transporters.
  • Egr-1 protein levels were not affected by MDMA, suggesting post-transcriptional regulation or rapid protein turnover.

Related Concept Videos